Radiation Oncology

Lung Cancer Control and Epidemiology

Tobacco Control and Primary Prevention
  1. Magnitude of the tobacco epidemic world wide
  2. Global efforts to curb use of tobacco products
  3. Possible impact of these efforts on mortality from lung cancer
Tobacco Cessation
  1. Overview about how lung cancer specialists should help their patients stop tobacco use
  2. Describe mechanisms about how persistent tobacco use affects cancer treatment
  3. Provide information about how to help patients stop tobacco use

 

Clinical and Radiologic Presentation of Lung Cancer

Clinical Presentation
  1. Symptoms and signs of non small cell lung cancer
  2. Symptoms and signs of small cell lung cancer
  3. Describe paraneoplastic and other syndromes associated with NSCLC
  4. Clinical and molecular methods for the prognostication of lung cancer
PET Imaging of Lung Cancer
  1. Role of FDG in diagnostic algorithm
  2. FDG pet in the prognostication of lung cancer
  3. FDG pet in the determination of response to therapy
  4. Novel tracers: FAZA, FLT

 

Surgical Management of Lung Cancer

Results of Video Assisted Techniques for Resection of Lung Cancer
  1. Definitions of VATS surgery for lung cancer, specifically pulmonary resections and different varieties of VATS
  2. How does it compare to standard resection both acute and late
  3. What are the benefits and the limitations?
  4. Evidence-based/meta/summary analyses of VATS vs Non-VATS

 

Radiotherapeutic Management of Lung Cancer

Patient Selection for Radiotherapy
  1. Patient-related factors (e.g. performance status, pulmonary function) and tumor-related factors (e.g. stage, tumor volume, SUV, molecular biomarkers
Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease
  1. Treatment of stage 1 disease with SBRT
  2. Treatment of oligometastatic disease with SBRT
Ablation Options for Localized Lung Cancer
  1. Discussion of catheter-related ablative therapies including RFA, microwave and cryo- and who are the candidates
  2. Theoretical immunological affects
  3. Results of treatment alone or in combination with other therapies, i.e. RT
Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality
  1. Radiotherapy dose fractionation and time for locally advanced disease
  2. Role type and timing of chemotherapy
  3. Combination with targeted agents
  4. Role of surgery (pros and cons)
  5. Prophylactic cranial irradiation
  6. Outcomes
Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation
  1. Indications for thoracic radiotherapy: volume, dose, fractionation, scheduling. Indications for prophylactic cranial irradiation; dose, fractionation, timing.
  2. Results of Therapy
Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic
  1. Indications for palliative radiotherapy (thorax, brain, bone, other).
  2. Dose, fractionation. Role in combination with other treatments (surgery, chemotherapy).
  3. Outcomes - symptom control, quality of life
Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart
  1. Pulmonary and heart
  2. Esophagus
  3. Quality of life
Treatment-Related Neurotoxicity, Medical and Radiation Therapy
  1. Early and late toxicity of cranial and spinal cord irradiation.
  2. Dose and volume factors
 

Chemotherapy and Targeted Agents for Lung Cancer

Front-Line Systemic Options in Non-Small Cell Lung Cancer
  1. Historical role of systemic therapy, evolution of systemic chemotherapy in NSCLC
  2. Oncogene addicted, therapeutic choices in lung adenocarcinoma
  3. Non-oncogene addicted, current therapeutic choices based on histology
Statistical methods and methodology of clinical trials
  1. Statistical measures for diagnostic accuracy measurement, and interrater agreement
  2. Design and endpoint considerations for imaging based studies
  3. Endpoints and Design considerations for radiation trials